Dermatology Billing // Modifier 25 // 2026

The Modifier 25 number every dermatology practice should watch in 2026

The modifier is number 25. The number that actually decides whether you keep the money is your own.

Significant, separately identifiable E/M

Lead with the answer. Watch your Modifier 25 rate: the share of biopsy or destruction days (CPT 11102–11107 and the rest of your minor-procedure book) where you also bill a same-day office E/M with Modifier 25. It is the single line item that predicts your same-day denial rate and your audit exposure. A high rate is not automatically wrong. An undocumented one is.

The number to watch

One ratio tells you where you stand

Pull it monthly from your PM system: same-day E/M claims carrying Modifier 25, divided by total minor-procedure encounters. Trend it by provider. The bands below are a governance trigger you set internally, not a payer threshold or a published cutoff.

Green: documented and stableRate holds steady month over month, and each Modifier 25 note stands on its own separate history, exam, and decision. Nothing to fix.

Amber: rising or provider-skewedOne provider trending well above peers, or a month-over-month climb with no volume reason. Pull ten charts and read the E/M notes before payers do.

Red: near-universal attachmentModifier 25 on almost every procedure day is the pattern NCCI edits and OIG audits look for. Not proof of error, but it is the flag that invites the request for records.

No external benchmark is quoted here on purpose. Set your own band from your specialty mix and prior audit history.

CPT 2026 · the procedures that trigger the question

Every biopsy in this family bundles a same-day E/M

The 2026 skin biopsy codes carry a global period, so a same-day office visit is packaged into the procedure unless you show it was significant and separate. That is exactly what Modifier 25 asserts. First biopsy uses the primary code; each additional lesion of the same method uses its add-on.

11102

Tangential biopsy, single lesion

+ 11103 each additional

11104

Punch biopsy, single lesion

+ 11105 each additional

11106

Incisional biopsy, single lesion

+ 11107 each additional

Same logic extends to destruction (17000 series) and lesion removals. The E/M has to earn its place on the claim.

The same-day edit

Why a clean-looking claim still denies

Patient presents

Rash check plus a suspicious lesion noted in the same visit.

E/M + biopsy billed

Office visit and 11104 on one date of service.

NCCI PTP edit fires

The E/M is bundled into the procedure. Without Modifier 25, it drops.

Modifier 25 unbundles

Only if the note proves a separate, significant service. Otherwise it is a takeback waiting to happen.

Modifier 25 is not a billing shortcut. Under the National Correct Coding Initiative it is a documentation claim, and the OIG has kept same-day E/M with minor procedures on its review radar for years. The modifier that bypasses the edit is the same modifier that invites the record request.

What makes it hold

The four tests a separately identifiable E/M has to pass

Under the CPT 2026 office and outpatient E/M framework, the visit is scored on medical decision making or time. For Modifier 25 to survive an audit, the E/M note has to read as a service that would stand on its own even if the biopsy had never happened.

Separate reason

A distinct complaint or a new problem beyond the lesion being biopsied. The eczema flare is not the mole.

Its own work

History, exam, and assessment that go past the pre-procedure look. Chart the decision, not just the finding.

Independent MDM

Decision making that would justify the E/M level on its own under the 2026 MDM table, procedure excluded.

Legible link

Modifier 25 on the E/M line, a separate diagnosis where clinically true, and a note a reviewer can follow in under a minute.

CPT does not require a separate diagnosis for Modifier 25, but a distinct dx makes the separate service obvious. Use it when the record supports it.

Holds vs fails

Same encounter, two different outcomes

Scenario	Modifier 25 holds	Modifier 25 fails
Reason for E/M	Documented new or unrelated problem addressed at the visit.	Note only describes the lesion that was biopsied.
Exam and history	Full ROS and exam elements beyond the procedure site.	A single line: “lesion noted, biopsy performed.”
Decision making	MDM stands alone under CPT 2026 without the biopsy.	All work is the pre-procedure evaluation of the same lesion.
Diagnosis coding	Distinct dx on the E/M where clinically supported.	Identical dx on E/M and procedure, no separate rationale.
Audit outcome	E/M survives review; payment stands.	Recoupment, and a pattern that draws the next review.

Guidelines this rests on

The 2026 rulebook, by name

CPT 2026

Office and outpatient E/M guidelines (99202–99215)Medical-decision-making or time scoring that determines whether a same-day E/M is substantive enough to bill separately.

CPT 2026

Skin biopsy codes 11102–11107Method-specific primary and add-on codes (tangential, punch, incisional) whose global period bundles the same-day visit.

NCCI

CMS National Correct Coding Initiative PTP edits and policy manualThe procedure-to-procedure edits that bundle E/M into minor procedures, and the modifier rules that govern the Modifier 25 override.

OIG

HHS Office of Inspector General review focus on Modifier 25Same-day E/M with minor procedures has been a recurring subject of OIG audits and Work Plan scrutiny.

CMS PFS

Medicare Physician Fee Schedule 2026 final ruleGlobal-period definitions and payment context for the office E/M and biopsy codes above.

Payers

Commercial same-day E/M editing policiesSeveral national plans apply their own Modifier 25 documentation edits and E/M adjustments. Check each payer’s current policy, they diverge from Medicare.

Know your Modifier 25 number before a payer audit finds it

ASP-RCM Solutions builds the dermatology billing discipline behind that ratio: same-day E/M edit checks before the claim goes out, chart-level Modifier 25 review, provider-by-provider trending, and appeal support when a defensible E/M gets pulled anyway. Fewer preventable denials, and a documentation trail that holds up.

Get a Modifier 25 risk read →

ASP-RCM Solutions · Dermatology Billing Services